Indeks Rilis Pers English

Visa cardholders worldwide to get early access to 2025 MAMA AWARDS tickets
PR Newswire
Senin, 13 Okt 2025

Visa cardholders worldwide to get early access to 2025 MAMA AWARDS tickets

Another Star-Studded Event in Hengqin Draws Global Attention
PR Newswire
Senin, 13 Okt 2025

Another Star-Studded Event in Hengqin Draws Global Attention

GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine
PR Newswire
Senin, 13 Okt 2025

GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine

Exploring Hunan First Normal University: The Spirit of Youth
PR Newswire
Senin, 13 Okt 2025

Exploring Hunan First Normal University: The Spirit of Youth

DXC Launches Assure Smart Apps to Accelerate AI-Driven Innovation in the Insurance Industry
PR Newswire
Senin, 13 Okt 2025

DXC Launches Assure Smart Apps to Accelerate AI-Driven Innovation in the Insurance Industry

MVGX Partners with World Free Zones Organisation to Launch ICER Book & Claim System
PR Newswire
Senin, 13 Okt 2025

MVGX Partners with World Free Zones Organisation to Launch ICER Book & Claim System

Global lead exposure still costs trillions and endangers children, NUS study finds
PR Newswire
Senin, 13 Okt 2025

Global lead exposure still costs trillions and endangers children, NUS study finds

Ampace Debuts Advanced Lithium and Next-Gen Semi-Solid-State Battery Technologies at Data Centre World Asia 2025
PR Newswire
Senin, 13 Okt 2025

Ampace Debuts Advanced Lithium and Next-Gen Semi-Solid-State Battery Technologies at Data Centre World Asia 2025

PFPFA Donates $100,000 to The Straits Times School Pocket Money Fund, Raising an Additional $64,000 at Charity Night 2025
PR Newswire
Senin, 13 Okt 2025

PFPFA Donates $100,000 to The Straits Times School Pocket Money Fund, Raising an Additional $64,000 at Charity Night 2025

Nippon Budokan to Showcase Japanese Martial Arts in Singapore for Republic's 60th Independence Anniversary
PR Newswire
Senin, 13 Okt 2025

Nippon Budokan to Showcase Japanese Martial Arts in Singapore for Republic's 60th Independence Anniversary

Singapore's First Professional 3x3 Basketball Team Reaches All-Time High in FIBA 3x3 World Rankings
PR Newswire
Senin, 13 Okt 2025

Singapore's First Professional 3x3 Basketball Team Reaches All-Time High in FIBA 3x3 World Rankings

WIP Capital Investments Pty Ltd (ACN 686 632 066) Issues Offer Letter to Prospective Note Subscribers
PR Newswire
Senin, 13 Okt 2025

WIP Capital Investments Pty Ltd (ACN 686 632 066) Issues Offer Letter to Prospective Note Subscribers

As an academy even older than University of Cambridge, the great wisdom, "seeking truth from facts", took root here
PR Newswire
Senin, 13 Okt 2025

As an academy even older than University of Cambridge, the great wisdom, "seeking truth from facts", took root here

Smartee Launches World's First Sleep Aligner Combining Anti-Snoring Therapy with Teeth Alignment
PR Newswire
Senin, 13 Okt 2025

Smartee Launches World's First Sleep Aligner Combining Anti-Snoring Therapy with Teeth Alignment

Agoda Data Shows 67% Rise in International Travel Interest to India During Diwali 2025
PR Newswire
Senin, 13 Okt 2025

Agoda Data Shows 67% Rise in International Travel Interest to India During Diwali 2025

CommScope and Nokia Announce Combined FTTH Solution
PR Newswire
Senin, 13 Okt 2025

CommScope and Nokia Announce Combined FTTH Solution

Trip.com Group and Live Nation Asia Announce Strategic Partnership to Power Concert Travel
PR Newswire
Senin, 13 Okt 2025

Trip.com Group and Live Nation Asia Announce Strategic Partnership to Power Concert Travel

Ramco Payce Now Certified with Workday Global Payroll Connect
PR Newswire
Senin, 13 Okt 2025

Ramco Payce Now Certified with Workday Global Payroll Connect

Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14
PR Newswire
Senin, 13 Okt 2025

Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14

Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development
PR Newswire
Senin, 13 Okt 2025

Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development